Utama › Kolitis Ulseratif › Georgia
Kajian klinikal Kolitis Ulseratif di Georgia
14 kajian untuk Kolitis Ulseratif sedang mencari peserta di lokasi di Georgia.
Bandar di Georgia
Teks kajian rasmi (Bahasa Inggeris)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates of Central Georgia /ID# 280464, Macon
- Gastroenterology Consultants - Roswell /ID# 281235, Roswell
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Digestive Healthcare of Georgia, Atlanta
- AGA GA Research LLC, Atlanta
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Childrens Center For Digestive Health Care /ID# 273228, Atlanta
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07071519A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Gastroenterology Associates of Central Georgia ( Site 1060), Macon
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Associates, Atlanta
- Children's Center for Digestive Health Care, Atlanta
- Gastroenterolgy Associates of Central GA, Macon
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
Mengambil pesertaFasa 3
Umur 3 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06663332A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Emory University School of Medicine, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
Mengambil pesertaFasa 3
Umur 2 hingga 19 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04844606A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
Mengambil pesertaFasa 4
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07513181A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Specialists, Suwanee
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Associates - Site Number: 8400109, Atlanta
- M3 Wake Research - Atlanta - Site Number: 8400028, Sandy Springs
- EBGS Clinical Research Center, LLC - Site Number: 8400037, Snellville
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07184996A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Center For Digestive Healthcare, Atlanta
Mengambil pesertaFasa 3
Umur 2 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Atlanta
- Mirador Therapeutics Selected Site, Snellville
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.